Two studies based on the analysis of the RNA-seq data of AML cases from TCGA found that U2AF1 mutations lead to aberrant gene splicing events in important biological pathways, such as cell cycle progression, RNA processing, and other cancer-related genes. Here, U2AF1 is linked to cancer.